JP2012511579A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511579A5 JP2012511579A5 JP2011540854A JP2011540854A JP2012511579A5 JP 2012511579 A5 JP2012511579 A5 JP 2012511579A5 JP 2011540854 A JP2011540854 A JP 2011540854A JP 2011540854 A JP2011540854 A JP 2011540854A JP 2012511579 A5 JP2012511579 A5 JP 2012511579A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- rsv
- arginine
- vlp
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12112608P | 2008-12-09 | 2008-12-09 | |
| US61/121,126 | 2008-12-09 | ||
| US16907709P | 2009-04-14 | 2009-04-14 | |
| US61/169,077 | 2009-04-14 | ||
| US22478709P | 2009-07-10 | 2009-07-10 | |
| US61/224,787 | 2009-07-10 | ||
| PCT/US2009/067269 WO2010077717A1 (en) | 2008-12-09 | 2009-12-09 | Modified rsv f proteins and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015124158A Division JP6162751B2 (ja) | 2008-12-09 | 2015-06-19 | 修飾ｒｓｖｆタンパク質及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012511579A JP2012511579A (ja) | 2012-05-24 |
| JP2012511579A5 true JP2012511579A5 (https=) | 2013-01-17 |
| JP5813513B2 JP5813513B2 (ja) | 2015-11-17 |
Family
ID=42310119
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540854A Active JP5813513B2 (ja) | 2008-12-09 | 2009-12-09 | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| JP2015124158A Active JP6162751B2 (ja) | 2008-12-09 | 2015-06-19 | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| JP2017118032A Active JP6462048B2 (ja) | 2008-12-09 | 2017-06-15 | 修飾ｒｓｖ ｆタンパク質及びその使用方法 |
| JP2018242108A Active JP6782289B2 (ja) | 2008-12-09 | 2018-12-26 | 修飾ｒｓｖ ｆタンパク質及びその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015124158A Active JP6162751B2 (ja) | 2008-12-09 | 2015-06-19 | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| JP2017118032A Active JP6462048B2 (ja) | 2008-12-09 | 2017-06-15 | 修飾ｒｓｖ ｆタンパク質及びその使用方法 |
| JP2018242108A Active JP6782289B2 (ja) | 2008-12-09 | 2018-12-26 | 修飾ｒｓｖ ｆタンパク質及びその使用方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (7) | US8715692B2 (https=) |
| EP (3) | EP3718566B1 (https=) |
| JP (4) | JP5813513B2 (https=) |
| KR (2) | KR101801213B1 (https=) |
| CN (2) | CN106146671B (https=) |
| AU (1) | AU2009333484B2 (https=) |
| BR (1) | BRPI0922867B8 (https=) |
| CA (1) | CA2746228C (https=) |
| CY (2) | CY1117757T1 (https=) |
| DK (2) | DK3067064T3 (https=) |
| ES (3) | ES2796725T3 (https=) |
| HR (2) | HRP20160859T1 (https=) |
| HU (2) | HUE051666T2 (https=) |
| IL (2) | IL213450B (https=) |
| LT (1) | LT3067064T (https=) |
| MX (4) | MX337932B (https=) |
| PL (2) | PL2370099T3 (https=) |
| PT (2) | PT3067064T (https=) |
| RU (1) | RU2531510C2 (https=) |
| SG (2) | SG172022A1 (https=) |
| SI (2) | SI3067064T1 (https=) |
| SM (1) | SMT202000411T1 (https=) |
| WO (1) | WO2010077717A1 (https=) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160000902A1 (en) * | 2003-07-11 | 2016-01-07 | Novavax, Inc. | Combination vaccine for respiratory syncytial virus and influenza |
| US20120093855A1 (en) * | 2008-11-18 | 2012-04-19 | Ligocyte Pharmaceuticals, Inc. | RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF |
| JP5813513B2 (ja) * | 2008-12-09 | 2015-11-17 | ノババックス，インコーポレイテッド | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| EP4218799A1 (en) | 2009-07-15 | 2023-08-02 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| US20110097358A1 (en) * | 2009-10-12 | 2011-04-28 | Techno Vax, Inc. | RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs) |
| BR112013011194B1 (pt) * | 2010-11-05 | 2020-12-22 | Novavax, Inc | partícula micelar, composição farmacêutica compreendendo a mesma, uso de uma partícula micelar e método de preparação de uma micela |
| WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| AU2012211278B2 (en) | 2011-01-26 | 2016-11-10 | Glaxosmithkline Biologicals Sa | RSV immunization regimen |
| DK2707385T3 (da) | 2011-05-13 | 2017-11-20 | Glaxosmithkline Biologicals Sa | RSV-F-præfusionsantigener |
| EP3275464A1 (en) * | 2011-08-01 | 2018-01-31 | Emory University | Vlps containing ligands and methods related thereto |
| WO2013031827A1 (ja) | 2011-08-29 | 2013-03-07 | 国立大学法人徳島大学 | Rsv粘膜ワクチン |
| US20130122032A1 (en) * | 2011-09-30 | 2013-05-16 | Gale Smith | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| MY171498A (en) * | 2012-08-01 | 2019-10-15 | Bavarian Nordic As | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
| EA201590683A1 (ru) | 2012-11-20 | 2015-11-30 | Глаксосмитклайн Байолоджикалс С.А. | Тримеры rsv f, предшествующие слиянию |
| US20140227309A1 (en) * | 2013-02-11 | 2014-08-14 | Novavax, Inc. | Combination vaccine for respiratory syncytial virus and influenza |
| CN113322264B (zh) * | 2013-03-14 | 2024-05-31 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
| DE102013004595A1 (de) * | 2013-03-15 | 2014-09-18 | Emergent Product Development Germany Gmbh | RSV-Impfstoffe |
| KR102399854B1 (ko) | 2013-09-19 | 2022-05-19 | 노바백스, 인코포레이티드 | 면역원성 중동호흡기증후군 코로나바이러스 (ΜＥＲＳ-ＣｏＶ) 조성물 및 방법 |
| EP2974739A1 (en) | 2014-07-15 | 2016-01-20 | Novartis AG | RSVF trimerization domains |
| US10100372B2 (en) | 2014-06-18 | 2018-10-16 | Georgia State University Research Foundation, Inc. | Recombinant RSV reporter virus |
| JP6824154B2 (ja) * | 2014-08-08 | 2021-02-03 | ブイエルピー・セラピューティクス・リミテッド・ライアビリティ・カンパニーＶＬＰ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ | 修飾エンベロープタンパク質ｅ３を含むウイルス様粒子 |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| ES2839880T3 (es) | 2015-07-07 | 2021-07-06 | Janssen Vaccines & Prevention Bv | Vacuna contra el VRS |
| EP4494650A3 (en) * | 2015-09-03 | 2025-03-26 | Novavax, Inc. | Vaccine compositions having improved stability and immunogenicity |
| MX2018005462A (es) | 2015-10-29 | 2018-08-01 | Univ Emory | Composiciones inmunogénicas de rsv quimérico y métodos de uso. |
| EP3393512B1 (en) | 2015-12-23 | 2025-11-19 | Pfizer Inc. | Rsv f protein mutants |
| KR102500970B1 (ko) * | 2016-04-05 | 2023-02-17 | 얀센 백신스 앤드 프리벤션 비.브이. | Rsv에 대한 백신 |
| PH12022552125A1 (en) * | 2016-04-05 | 2023-04-12 | Janssen Vaccines & Prevention Bv | Stabilized soluble pre-fusion rsv f proteins |
| IL264119B2 (en) | 2016-05-30 | 2023-04-01 | Janssen Vaccines Prevention B V | f proteins of rsv are stabilized before fusion |
| CN106011086A (zh) * | 2016-06-15 | 2016-10-12 | 湖北省农业科学院畜牧兽医研究所 | 表达信号肽替换的呼吸道合胞病毒f蛋白的重组新城疫耐热疫苗株及制备方法 |
| EP3595713A4 (en) * | 2017-03-15 | 2021-01-13 | ModernaTX, Inc. | RESPIRATORY SYNCYTIAL VIRUS Vaccine |
| MX2019011599A (es) * | 2017-03-30 | 2019-12-19 | Univ Queensland | Moleculas quimericas y usos de las mismas. |
| KR102774312B1 (ko) | 2017-04-04 | 2025-03-05 | 유니버시티 오브 워싱톤 | 파라믹소바이러스 및/또는 뉴모바이러스 f 단백질을 표시하는 자가-조립 단백질 나노구조체 및 이의 용도 |
| BR112019026434A2 (pt) | 2017-06-14 | 2020-07-14 | Virometix Ag | peptídeos cíclicos para proteção contra vírus sincicial respiratório |
| WO2019023196A1 (en) | 2017-07-24 | 2019-01-31 | Novavax, Inc. | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE |
| WO2019148101A1 (en) | 2018-01-29 | 2019-08-01 | Modernatx, Inc. | Rsv rna vaccines |
| CA3095216A1 (en) | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| EP3768308A4 (en) | 2018-03-19 | 2022-01-26 | Novavax, Inc. | MULTIVALENT INFLUENZA NANOPARTICLE VACCINES |
| EP3775174A4 (en) * | 2018-03-30 | 2022-07-06 | Georgia State University Research Foundation, Inc. | Respiratory syncytial virus (rsv) vaccines |
| BR112020019938A2 (pt) | 2018-04-03 | 2021-01-26 | Sanofi | polipeptídeos antigênicos de vírus sincicial respiratório |
| US12370252B2 (en) | 2018-10-29 | 2025-07-29 | Emory University | RSV virus-like particles and methods of use thereof |
| KR102725189B1 (ko) * | 2018-11-01 | 2024-10-31 | 에스케이바이오사이언스(주) | 재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물 |
| JP2022513025A (ja) | 2018-11-13 | 2022-02-07 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 安定化された融合前ｒｓｖ ｆタンパク質 |
| EP3897708A1 (en) | 2018-12-20 | 2021-10-27 | Virometix AG | Lipopeptide building blocks and synthetic virus-like particles |
| KR20210126075A (ko) * | 2019-02-11 | 2021-10-19 | 에모리 유니버시티 | 키메라 rsv 및 hmpv f 단백질, 면역원성 조성물, 및 사용 방법 |
| AU2020227545B2 (en) | 2019-02-28 | 2023-10-19 | Km Biologics Co., Ltd. | RSV F/G chimeric vaccine |
| CA3165371A1 (en) * | 2020-01-27 | 2021-08-05 | Gale Smith | Coronavirus vaccine formulations |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| EP3901261A1 (en) | 2020-04-22 | 2021-10-27 | BioNTech RNA Pharmaceuticals GmbH | Coronavirus vaccine |
| CN113855796B (zh) * | 2021-07-30 | 2024-01-26 | 河北医科大学 | 卡介苗作为呼吸道合胞病毒灭活疫苗佐剂的应用 |
| WO2023062651A1 (en) * | 2021-10-13 | 2023-04-20 | Padmanabh Patil Harshad | Virus-like particles for respiratory syncytial virus and method of preparation thereof |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| US20240076320A1 (en) * | 2022-09-01 | 2024-03-07 | Novavax, Inc. | Downstream process for purification of viral proteins with hydrophobic membrane domain for use in vaccine compositions |
| CN115927751B (zh) * | 2022-09-17 | 2024-12-20 | 宁夏大学 | 牛呼吸道合胞体病毒实时荧光定量pcr检测的引物探针组及检测方法 |
| JP2026510670A (ja) * | 2023-03-17 | 2026-04-10 | 成都威斯克生物医▲薬▼有限公司 | 呼吸器合胞体ウイルス感染症に対するワクチン |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| CN119504955A (zh) * | 2023-08-25 | 2025-02-25 | 深圳瑞吉生物科技有限公司 | 呼吸道合胞病毒抗原性多肽、核酸及疫苗 |
| WO2025051250A1 (zh) * | 2023-09-07 | 2025-03-13 | 北京科兴中维生物技术有限公司 | 呼吸道合胞病毒f蛋白及其应用 |
| US20250144200A1 (en) | 2023-11-06 | 2025-05-08 | Novavax, Inc. | Intranasal immunogenic compositions |
| CN117645655B (zh) * | 2024-01-26 | 2024-05-24 | 普大生物科技(泰州)有限公司 | 一种肺炎球菌多糖-rsv重组蛋白结合疫苗及其制备方法 |
| WO2025201243A1 (zh) * | 2024-03-25 | 2025-10-02 | 中国医学科学院医学生物学研究所 | 重组呼吸道合胞病毒融合前f蛋白突变体和其用途 |
| CN118146321B (zh) * | 2024-03-27 | 2024-08-27 | 普大生物科技(泰州)有限公司 | 一种rsv重组蛋白疫苗及其制备方法 |
| CN118480560B (zh) * | 2024-07-09 | 2024-11-26 | 北京悦康科创医药科技股份有限公司 | 呼吸道合胞病毒mRNA疫苗及其制备方法和应用 |
| CN119161422B (zh) * | 2024-08-26 | 2026-04-03 | 扬州大学 | 一种呼吸道合胞病毒融合前f蛋白及其应用 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5149650A (en) | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
| US6387373B1 (en) | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| ES2370937T3 (es) | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| US5629021A (en) | 1995-01-31 | 1997-05-13 | Novavax, Inc. | Micellar nanoparticles |
| SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Bror Morein | Ny användning |
| US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
| AUPO517897A0 (en) | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
| CA2355270A1 (en) | 1998-12-17 | 2000-06-22 | Aventis Pasteur Limited | Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| EP2420247A1 (en) | 2000-03-07 | 2012-02-22 | Merck Sharp & Dohme Corp. | Adenovirus formulations |
| KR20030055275A (ko) | 2000-10-02 | 2003-07-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 분할 외피 바이러스 제조물 |
| WO2003068163A2 (en) | 2002-02-14 | 2003-08-21 | Novavax, Inc. | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| WO2005027825A2 (en) | 2003-04-25 | 2005-03-31 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| JP4750024B2 (ja) * | 2003-06-20 | 2011-08-17 | プロテイン サイエンシーズ コーポレイション | Ｓａｒｓの免疫原を発現するベクター、そのようなベクター又はその発現産物を含有する組成物、並びにその作製及び使用の方法及びアッセイ |
| WO2005080417A2 (en) | 2003-12-10 | 2005-09-01 | The Uab Research Foundation | Recombinant viruses with heterologous envelope proteins |
| WO2007011396A2 (en) | 2004-10-29 | 2007-01-25 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
| JP2008537482A (ja) | 2005-03-10 | 2008-09-18 | メッドイミューン バクシーンズ，インコーポレイティド | メタニューモウイルス株、およびワクチン製剤におけるその使用および抗原配列発現用ベクターとしてのその使用、ならびにウイルスの増殖法 |
| US9216212B2 (en) | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| WO2007149490A1 (en) | 2006-06-19 | 2007-12-27 | Progenics Pharmaceuticals, Inc. | Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins |
| US20080233150A1 (en) | 2006-11-16 | 2008-09-25 | Gale Smith | Respiratory syncytial virus-virus like particle (vlps) |
| US8772256B2 (en) * | 2006-11-30 | 2014-07-08 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Codon modified immunogenic compositions and methods of use |
| EP1972348A1 (en) * | 2007-03-14 | 2008-09-24 | Pierre Fabre Medicament | Novel vaccine composition for the treatment of respiratory infectious diseases |
| JP2010522540A (ja) * | 2007-03-21 | 2010-07-08 | アイディー バイオメディカル コーポレイション オブ ケベック | キメラ抗原 |
| HUE025702T2 (en) | 2007-07-19 | 2016-04-28 | Novavax Inc | Avian Flu Chimeric VLPs |
| US20100239671A1 (en) | 2007-11-06 | 2010-09-23 | Edelman Elazer R | Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
| PL2222710T3 (pl) | 2007-12-24 | 2017-01-31 | Id Biomedical Corporation Of Quebec | Rekombinowane antygeny rsv |
| JP2011514337A (ja) | 2008-02-25 | 2011-05-06 | ノババックス，インコーポレイテッド | 糖ガラス化ウィルス様粒子（ｖｌｐ） |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| JP5813513B2 (ja) | 2008-12-09 | 2015-11-17 | ノババックス，インコーポレイテッド | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| CA2762653A1 (en) | 2009-05-27 | 2010-12-02 | Selecta Biosciences, Inc. | Immunomodulatory agent-polymeric compounds |
| MX2012000035A (es) * | 2009-06-24 | 2012-02-28 | Id Biomedical Corp Quebec | Antigenos de virus de sincicio respiratorio recombinantes. |
| EP4218799A1 (en) * | 2009-07-15 | 2023-08-02 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| BR112013011194B1 (pt) | 2010-11-05 | 2020-12-22 | Novavax, Inc | partícula micelar, composição farmacêutica compreendendo a mesma, uso de uma partícula micelar e método de preparação de uma micela |
| CN102107003A (zh) | 2011-01-05 | 2011-06-29 | 重庆大学 | 一种猪繁殖与呼吸综合症病毒体疫苗及其制备方法 |
| US11058762B2 (en) | 2011-07-06 | 2021-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| US20130122032A1 (en) | 2011-09-30 | 2013-05-16 | Gale Smith | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| US20140227309A1 (en) | 2013-02-11 | 2014-08-14 | Novavax, Inc. | Combination vaccine for respiratory syncytial virus and influenza |
| RU2531235C2 (ru) | 2013-02-15 | 2014-10-20 | Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") | Поливалентная вакцина против гриппа на основе гибридного белка |
| JP6469081B2 (ja) | 2013-04-25 | 2019-02-13 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 安定化された可溶性融合前ｒｓｖｆポリペプチド |
| AU2014100888A4 (en) | 2014-08-07 | 2014-09-11 | Novartis Ag | Virus clearance and protein purification methods |
| WO2017000105A1 (zh) * | 2015-06-29 | 2017-01-05 | 尚平 | 便携式加湿器 |
| EP4494650A3 (en) | 2015-09-03 | 2025-03-26 | Novavax, Inc. | Vaccine compositions having improved stability and immunogenicity |
-
2009
- 2009-12-09 JP JP2011540854A patent/JP5813513B2/ja active Active
- 2009-12-09 SI SI200932062T patent/SI3067064T1/sl unknown
- 2009-12-09 HU HUE16166033A patent/HUE051666T2/hu unknown
- 2009-12-09 SG SG2011041696A patent/SG172022A1/en unknown
- 2009-12-09 RU RU2011128371/10A patent/RU2531510C2/ru active
- 2009-12-09 CN CN201610520252.6A patent/CN106146671B/zh active Active
- 2009-12-09 PT PT161660337T patent/PT3067064T/pt unknown
- 2009-12-09 MX MX2014011966A patent/MX337932B/es unknown
- 2009-12-09 EP EP20171841.8A patent/EP3718566B1/en active Active
- 2009-12-09 HR HRP20160859TT patent/HRP20160859T1/hr unknown
- 2009-12-09 PL PL09836751.9T patent/PL2370099T3/pl unknown
- 2009-12-09 BR BRPI0922867A patent/BRPI0922867B8/pt active IP Right Grant
- 2009-12-09 DK DK16166033.7T patent/DK3067064T3/da active
- 2009-12-09 US US12/633,995 patent/US8715692B2/en active Active
- 2009-12-09 KR KR1020167035029A patent/KR101801213B1/ko active Active
- 2009-12-09 SM SM20200411T patent/SMT202000411T1/it unknown
- 2009-12-09 SI SI200931470A patent/SI2370099T1/sl unknown
- 2009-12-09 ES ES16166033T patent/ES2796725T3/es active Active
- 2009-12-09 HU HUE09836751A patent/HUE029037T2/en unknown
- 2009-12-09 DK DK09836751.9T patent/DK2370099T3/en active
- 2009-12-09 ES ES09836751.9T patent/ES2582005T3/es active Active
- 2009-12-09 SG SG10201500161XA patent/SG10201500161XA/en unknown
- 2009-12-09 PL PL16166033T patent/PL3067064T3/pl unknown
- 2009-12-09 AU AU2009333484A patent/AU2009333484B2/en active Active
- 2009-12-09 MX MX2016003771A patent/MX345700B/es unknown
- 2009-12-09 CA CA2746228A patent/CA2746228C/en active Active
- 2009-12-09 WO PCT/US2009/067269 patent/WO2010077717A1/en not_active Ceased
- 2009-12-09 ES ES20171841T patent/ES2987238T3/es active Active
- 2009-12-09 PT PT98367519T patent/PT2370099T/pt unknown
- 2009-12-09 EP EP16166033.7A patent/EP3067064B1/en active Active
- 2009-12-09 CN CN200980156344.9A patent/CN102307591B/zh active Active
- 2009-12-09 EP EP09836751.9A patent/EP2370099B1/en active Active
- 2009-12-09 MX MX2011006205A patent/MX2011006205A/es active IP Right Grant
- 2009-12-09 MX MX2017001924A patent/MX358836B/es unknown
- 2009-12-09 LT LTEP16166033.7T patent/LT3067064T/lt unknown
- 2009-12-09 KR KR1020117015954A patent/KR101691574B1/ko active Active
-
2011
- 2011-06-09 IL IL213450A patent/IL213450B/en active IP Right Grant
-
2014
- 2014-03-21 US US14/221,675 patent/US9675685B2/en active Active
-
2015
- 2015-06-04 US US14/730,805 patent/US9731000B2/en active Active
- 2015-06-04 US US14/730,809 patent/US9717786B2/en active Active
- 2015-06-19 JP JP2015124158A patent/JP6162751B2/ja active Active
- 2015-08-28 US US14/839,247 patent/US10022437B2/en active Active
-
2016
- 2016-07-11 CY CY20161100652T patent/CY1117757T1/el unknown
- 2016-08-18 IL IL247341A patent/IL247341B/en active IP Right Grant
-
2017
- 2017-06-15 JP JP2017118032A patent/JP6462048B2/ja active Active
-
2018
- 2018-06-15 US US16/009,257 patent/US11052146B2/en active Active
- 2018-12-26 JP JP2018242108A patent/JP6782289B2/ja active Active
-
2020
- 2020-05-29 CY CY20201100490T patent/CY1123152T1/el unknown
- 2020-06-02 HR HRP20200871TT patent/HRP20200871T1/hr unknown
-
2022
- 2022-08-10 US US17/818,887 patent/US12357684B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511579A5 (https=) | ||
| RU2011128371A (ru) | Модифицированные f протеины sv и способы их применения | |
| EP1631663B1 (en) | High titer recombinant influenza viruses for vaccines and gene therapy | |
| Webster et al. | Molecular mechanisms of variation in influenza viruses | |
| EP2010557B1 (en) | High titer recombinant influenza viruses for vaccines | |
| JP2022066209A (ja) | Ｍｄｃｋ、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス | |
| US7723094B2 (en) | Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy | |
| ES2869199T3 (es) | Sistemas de expresión | |
| Elkashif et al. | Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections | |
| JP2011182797A5 (https=) | ||
| JP2015119730A5 (https=) | ||
| HRP20171213T1 (hr) | Glikoproteinske čestice nalik virusu (vlp) bjesnoće | |
| RU2015138530A (ru) | Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа | |
| KR20120096874A (ko) | 재조합 변형된 백시니아 앙카라 바이러스에 기반한 보편적 인플루엔자 백신 | |
| JP2008522621A (ja) | 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン | |
| ZA202100386B (en) | Influenza virus hemagglutinin mutants | |
| CN104195154B (zh) | 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用 | |
| WO2024141786A2 (en) | Multitarget vaccines and therapeutics | |
| Wang et al. | Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens | |
| WO2005115448A8 (en) | Multi plasmid system for the production of influenza virus | |
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| CN105671002A (zh) | H9n2亚型禽流感病毒细胞高产疫苗株构建及应用 | |
| WO2022037095A1 (zh) | 优化的表达新型冠状病毒抗原的核苷酸序列及其应用 | |
| Qin et al. | H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice | |
| ES2966636T3 (es) | Proteína recombinante vp60 y procedimiento para su producción y purificación |